CSIMarket Company Name, Ticker, Competitors, else..
 
Gritstone Bio Inc   (NASDAQ: GRTS)
 
Price: $0.0322 $-0.02 -31.780%
Day's High: $0.0403 Week Perf: -53.06 %
Day's Low: $ 0.03 30 Day Perf: -94.87 %
Volume (M): 61,018 52 Wk High: $ 0.00
Volume (M$): $ 1,965 52 Wk Avg: $0.00
Open: $0.04 52 Wk Low: $0.00



 Market Capitalization (Millions $) 5
 Shares Outstanding (Millions) 143
 Employees 98
 Revenues (TTM) (Millions $) 15
 Net Income (TTM) (Millions $) -201
 Cash Flow (TTM) (Millions $) 8
 Capital Exp. (TTM) (Millions $) 1

Gritstone Bio Inc
Gritstone Bio Inc is a biotechnology company that focuses on developing personalized cancer immunotherapies. They utilize a unique approach called argeted epitope discovery to identify and validate tumor-specific antigens, which are then used to create personalized immunotherapies that specifically target and destroy cancer cells. Gritstone Bio aims to improve the outcomes of cancer patients by developing innovative and effective immunotherapies.


   Company Address: 5959 Horton Street Emeryville 94608 CA
   Company Phone Number: 871-6100   Stock Exchange / Ticker: NASDAQ GRTS


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ALEC        7.44% 
ARMP   -4.55%    
MRNA        13.89% 
NVAX   -1.75%    
STRO   -4.05%    
TCON      0% 
• View Complete Report
   



Clinical Study

Gritstone bio Announces Interim Phase 2 Data for GRANITE Individualized Neoantigen Targeting Immunotherapy in Frontli...

Published Mon, Sep 30 2024 8:05 PM UTC

Breaking Ground: Promising Phase 2 Data for Gritstone bio s GRANITE Immunotherapy in Colorectal CancerIn a significant stride towards advancing cancer immunotherapy, Gritstone bio has announced promising interim data from its Phase 2 trial of GRANITE, an individualized neoantigen-targeting immunotherapy designed for frontline treatment in patients with metastatic microsatel...
Announcement

Gritstone Bio, Inc. Faces Securities Class Action The Impact and Importance of Secure Legal Counsel

Published Sun, Jun 30 2024 1:30 PM UTC

In an exclusive report by CSIMarket.com , we delve into the recent developments surrounding Gritstone Bio, Inc. and its ongoing securities class action lawsuit. Trusted and leading law firm, Rosen, highlights the significance of securing legal counsel before the approaching deadline. The case encompasses the period from March 9, 2023, to February 29, 2024, and investors mus...
Financing Agreement

Gritstone Bio Announces Inducement Grants as it Envisions Development of Powerful Vaccines

Published Thu, Jun 13 2024 11:00 AM UTC



In a recent announcement, Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company committed to revolutionizing vaccine development, revealed the grant of nonqualified stock options to a new employee. These stock options, totaling 6,850 shares of common stock, carry an exercise price of $0.75, mirroring the closing price of Gritstone s common stoc...
Clinical Study

Gritstone bio?s Self-Amplifying mRNA (samRNA) Vaccine Demonstrates Long-lasting Immune Response Against COVID-19 Variants

Published Tue, Apr 30 2024 11:00 AM UTC

The ongoing battle against the COVID-19 pandemic has emphasized the crucial role of effective vaccines in controlling the spread of the virus. With new variants emerging, it is imperative to develop vaccines that provide durable immunity and broad utility. Gritstone bio, a pioneering biotechnology company, presented promising data on the durability and potential broad utilit...
Product Service News

Revolutionizing Cancer Vaccines: Gritstone Bio's Breakthrough SLATE Platform Unveils Potent KRAS-Specific Candidate

Published Mon, Apr 15 2024 11:00 AM UTC

Revolutionizing Cancer Vaccines: Gritstone Bio s Breakthrough SLATE Platform Unveils Potent KRAS-Specific CandidateNature Medicine has recently published the interim results of Gritstone Bio s Phase 1/2 study, shedding light on the design optimization process of their off-the-shelf neoantigen vaccine platform, known as SLATE. This groundbreaking development holds immense pro...






Gritstone Bio Inc's Segments





Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.